Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK.
Greater Manchester Comprehensive Stroke Centre, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK.
Acta Neurol Belg. 2021 Apr;121(2):379-385. doi: 10.1007/s13760-019-01148-w. Epub 2019 Apr 29.
Whilst stroke-associated pneumonia (SAP) is common and associated with poor outcomes, less is known about the determinants of these adverse clinical outcomes in SAP. To identify the factors that influence mortality and morbidity in SAP. Data for patients with SAP (n = 854) were extracted from a regional Hospital Stroke Register in Norfolk, UK (2003-2015). SAP was defined as pneumonia occurring within 7 days of admission by the treating clinicians. Mutlivariable regression models were constructed to assess factors influencing survival and the level of disability at discharge using modified Rankin Scale [mRS]. Mean (SD) age was 83.0 (8.7) years and ischaemic stroke occurred in 727 (85.0%). Mortality was 19.0% at 30 days and 44.0% at 6 months. Stroke severity assessment using National Institutes of Health Stroke Scale was not recorded in the data set although Oxfordshire Community Stroke Project was Classification. In the multivariable analyses, 30-day mortality was independently associated with age (OR 1.04, 95% CI 1.01-1.07, p = 0.01), haemorrhagic stroke (2.27, 1.07-4.78, p = 0.03) and pre-stroke disability (mRS 4-5 v 0-1: 6.45, 3.12-13.35, p < 0.001). 6-month mortality was independently associated with age (< 0.001), pre-stroke disability (p < 0.001) and certain comorbidities, including the following: dementia (6.53, 4.73-9.03, p < 0.001), lung cancer (2.07, 1.14-3.77, p = 0.017) and previous transient ischemic attack (1.94, 1.12-3.36, p = 0.019). Disability defined by mRS at discharge was independently associated with age (1.10, 1.05-1.16, p < 0.001) and plasma C-reactive protein (1.02, 1.01-1.03, p = 0.012). We have identified non-modifiable determinants of poor prognosis in patients with SAP. Further studies are required to identify modifiable factors which may guide areas for intervention to improve the prognosis in SAP in these patients.
虽然卒中相关性肺炎(SAP)很常见,且与不良预后相关,但人们对 SAP 不良临床结局的决定因素知之甚少。为了确定影响 SAP 患者死亡率和发病率的因素。从英国诺福克郡的一个区域医院卒中登记处(2003-2015 年)提取了 SAP 患者的数据(n=854)。SAP 是指由治疗医生在入院后 7 天内诊断的肺炎。使用改良 Rankin 量表(mRS)构建多变量回归模型来评估影响生存和出院时残疾程度的因素。平均(SD)年龄为 83.0(8.7)岁,缺血性卒中占 727 例(85.0%)。30 天死亡率为 19.0%,6 个月死亡率为 44.0%。数据集未记录卒中严重程度评估,即国立卫生研究院卒中量表评分,但使用了牛津郡社区卒中项目分类。在多变量分析中,30 天死亡率与年龄(OR 1.04,95%CI 1.01-1.07,p=0.01)、出血性卒中(2.27,1.07-4.78,p=0.03)和卒中前残疾(mRS 4-5 v 0-1:6.45,3.12-13.35,p<0.001)独立相关。6 个月死亡率与年龄(<0.001)、卒中前残疾(p<0.001)和某些合并症独立相关,包括以下内容:痴呆(6.53,4.73-9.03,p<0.001)、肺癌(2.07,1.14-3.77,p=0.017)和既往短暂性脑缺血发作(1.94,1.12-3.36,p=0.019)。出院时 mRS 定义的残疾与年龄(1.10,1.05-1.16,p<0.001)和血浆 C 反应蛋白(1.02,1.01-1.03,p=0.012)独立相关。我们已经确定了 SAP 患者预后不良的不可变决定因素。需要进一步研究以确定可改变的因素,这可能为改善这些患者 SAP 的预后提供指导。